D3 Pharma is a privately owned specialty pharmaceutical company based in the United Kingdom.
It is committed to the research, development and commercialisation of licensed high-strength vitamin D medicinal products for the treatment of vitamin D deficiency, insufficiency and associated conditions.
D3 Pharma’s pioneering work in the vitamin D deficiency area aims to address a significant unmet need and improve product access in the UK, Europe and worldwide. Our goal is to provide physicians, nutritionists and other healthcare professionals with high-quality, high-strength, clinically effective vitamin D3 products that can be used to provide rapid repletion and maintenance of vitamin D levels in both children and adults. Our high-strength product range will include vitamin D3 (cholecalciferol) at oral doses of 20,000 and 40,000 International Units (IU).
Company Details
- Founded
- 2009
- Address
- The Carriage House, Mill Street,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- d3-pharma.com
- HQ
- Maidstone, Kent
D3 Pharma Limited Questions
D3 Pharma Limited's website is d3-pharma.com
D3 Pharma Limited's LinkedIn profile is https://uk.linkedin.com/company/d3-pharma-limited
D3 Pharma Limited's industry is
Pharmaceutical Manufacturing
D3 Pharma Limited's top competitors are
Galvany Pharma Limited,
Troo Health Care Ltd,
Cbb Pharma Ltd,
Wickham Micro Limited - A Cormica Lab,
Pfizer,
Synergy Biologics,
Hoeford Research Limited,
Centrical Global Limited,
Kinerva Ltd,
H2 Pharma Consulting Limited.
D3 Pharma Limited's categories are Pharmaceutical Manufacturing
D3 Pharma Limited's founding year is 2009
